132 related articles for article (PubMed ID: 32387251)
41. Pause induced early afterdepolarizations in the long QT syndrome: a simulation study.
Viswanathan PC; Rudy Y
Cardiovasc Res; 1999 May; 42(2):530-42. PubMed ID: 10533588
[TBL] [Abstract][Full Text] [Related]
42. Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes.
Rocchetti M; Sala L; Dreizehnter L; Crotti L; Sinnecker D; Mura M; Pane LS; Altomare C; Torre E; Mostacciuolo G; Severi S; Porta A; De Ferrari GM; George AL; Schwartz PJ; Gnecchi M; Moretti A; Zaza A
Cardiovasc Res; 2017 Apr; 113(5):531-541. PubMed ID: 28158429
[TBL] [Abstract][Full Text] [Related]
43. Pharmacological activation of IKr in models of long QT Type 2 risks overcorrection of repolarization.
Perry MD; Ng CA; Mangala MM; Ng TYM; Hines AD; Liang W; Xu MJO; Hill AP; Vandenberg JI
Cardiovasc Res; 2020 Jul; 116(8):1434-1445. PubMed ID: 31628797
[TBL] [Abstract][Full Text] [Related]
44. Curcumin, a dietary natural supplement, prolongs the action potential duration of KCNE1-D85N-induced pluripotent stem cell-derived cardiomyocytes.
Martinez K; Smith A; Ye D; Zhou W; Tester DJ; Ackerman MJ
Heart Rhythm; 2023 Apr; 20(4):580-586. PubMed ID: 36586707
[TBL] [Abstract][Full Text] [Related]
45. α1-Syntrophin Variant Identified in Drug-Induced Long QT Syndrome Increases Late Sodium Current.
Choi JI; Wang C; Thomas MJ; Pitt GS
PLoS One; 2016; 11(3):e0152355. PubMed ID: 27028743
[TBL] [Abstract][Full Text] [Related]
46. Common Ancestry-Specific Ion Channel Variants Predispose to Drug-Induced Arrhythmias.
Wada Y; Yang T; Shaffer CM; Daniel LL; Glazer AM; Davogustto GE; Lowery BD; Farber-Eger EH; Wells QS; Roden DM
Circulation; 2022 Jan; 145(4):299-308. PubMed ID: 34994586
[TBL] [Abstract][Full Text] [Related]
47. A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes.
El-Battrawy I; Albers S; Cyganek L; Zhao Z; Lan H; Li X; Xu Q; Kleinsorge M; Huang M; Liao Z; Zhong R; Rudic B; Müller J; Dinkel H; Lang S; Diecke S; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou X; Akin I
Europace; 2019 Sep; 21(9):1410-1421. PubMed ID: 31106349
[TBL] [Abstract][Full Text] [Related]
48. A pore-localizing CACNA1C-E1115K missense mutation, identified in a patient with idiopathic QT prolongation, bradycardia, and autism spectrum disorder, converts the L-type calcium channel into a hybrid nonselective monovalent cation channel.
Ye D; Tester DJ; Zhou W; Papagiannis J; Ackerman MJ
Heart Rhythm; 2019 Feb; 16(2):270-278. PubMed ID: 30172029
[TBL] [Abstract][Full Text] [Related]
49. Optogenetic modulation of cardiac action potential properties may prevent arrhythmogenesis in short and long QT syndromes.
Gruber A; Edri O; Huber I; Arbel G; Gepstein A; Shiti A; Shaheen N; Chorna S; Landesberg M; Gepstein L
JCI Insight; 2021 Jun; 6(11):. PubMed ID: 34100384
[TBL] [Abstract][Full Text] [Related]
50. Sex-Related Differences in Drug-Induced QT Prolongation and Torsades de Pointes: A New Model System with Human iPSC-CMs.
Huo J; Wei F; Cai C; Lyn-Cook B; Pang L
Toxicol Sci; 2019 Feb; 167(2):360-374. PubMed ID: 30247688
[TBL] [Abstract][Full Text] [Related]
51. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
[TBL] [Abstract][Full Text] [Related]
52. Propranolol Attenuates Late Sodium Current in a Long QT Syndrome Type 3-Human Induced Pluripotent Stem Cell Model.
Hirose S; Makiyama T; Melgari D; Yamamoto Y; Wuriyanghai Y; Yokoi F; Nishiuchi S; Harita T; Hayano M; Kohjitani H; Gao J; Kashiwa A; Nishikawa M; Wu J; Yoshimoto J; Chonabayashi K; Ohno S; Yoshida Y; Horie M; Kimura T
Front Cell Dev Biol; 2020; 8():761. PubMed ID: 32903469
[TBL] [Abstract][Full Text] [Related]
53. Oxytocin exerts harmful cardiac repolarization prolonging effects in drug-induced LQTS.
Kreifels P; Bodi I; Hornyik T; Franke G; Perez-Feliz S; Lewetag R; Moss R; Castiglione A; Ziupa D; Zehender M; Brunner M; Bode C; Odening KE
Int J Cardiol Heart Vasc; 2022 Jun; 40():101001. PubMed ID: 35391783
[TBL] [Abstract][Full Text] [Related]
54. Allele-specific ablation rescues electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a CALM2 mutation.
Yamamoto Y; Makiyama T; Harita T; Sasaki K; Wuriyanghai Y; Hayano M; Nishiuchi S; Kohjitani H; Hirose S; Chen J; Yokoi F; Ishikawa T; Ohno S; Chonabayashi K; Motomura H; Yoshida Y; Horie M; Makita N; Kimura T
Hum Mol Genet; 2017 May; 26(9):1670-1677. PubMed ID: 28335032
[TBL] [Abstract][Full Text] [Related]
55. Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay.
Qu Y; Gao B; Fang M; Vargas HM
J Pharmacol Toxicol Methods; 2013; 68(1):74-81. PubMed ID: 23518063
[TBL] [Abstract][Full Text] [Related]
56. Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes.
Song Y; Shryock JC; Wu L; Belardinelli L
J Cardiovasc Pharmacol; 2004 Aug; 44(2):192-9. PubMed ID: 15243300
[TBL] [Abstract][Full Text] [Related]
57. Disease characterization using LQTS-specific induced pluripotent stem cells.
Egashira T; Yuasa S; Suzuki T; Aizawa Y; Yamakawa H; Matsuhashi T; Ohno Y; Tohyama S; Okata S; Seki T; Kuroda Y; Yae K; Hashimoto H; Tanaka T; Hattori F; Sato T; Miyoshi S; Takatsuki S; Murata M; Kurokawa J; Furukawa T; Makita N; Aiba T; Shimizu W; Horie M; Kamiya K; Kodama I; Ogawa S; Fukuda K
Cardiovasc Res; 2012 Sep; 95(4):419-29. PubMed ID: 22739119
[TBL] [Abstract][Full Text] [Related]
58. Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model.
Wang Z; Wang L; Liu W; Hu D; Gao Y; Ge Q; Liu X; Li L; Wang Y; Wang S; Li C
Stem Cell Res; 2019 Jul; 38():101483. PubMed ID: 31226583
[TBL] [Abstract][Full Text] [Related]
59. Identification of an I
Ma D; Liu Z; Loh LJ; Zhao Y; Li G; Liew R; Islam O; Wu J; Chung YY; Teo WS; Ching CK; Tan BY; Chong D; Ho KL; Lim P; Yong RYY; Panama BK; Kaplan AD; Bett GCL; Ware J; Bezzina CR; Verkerk AO; Cook SA; Rasmusson RL; Wei H
Sci Rep; 2018 Jul; 8(1):11246. PubMed ID: 30050137
[TBL] [Abstract][Full Text] [Related]
60. The disease-specific phenotype in cardiomyocytes derived from induced pluripotent stem cells of two long QT syndrome type 3 patients.
Fatima A; Kaifeng S; Dittmann S; Xu G; Gupta MK; Linke M; Zechner U; Nguemo F; Milting H; Farr M; Hescheler J; Sarić T
PLoS One; 2013; 8(12):e83005. PubMed ID: 24349418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
